Richard Pazdur | search
Click here to view Richard Pazdur news from 60+ newspapers.
Bookmark or Share- AACR: FDA's Richard Pazdur explains confirmatory trial rejection, moreFew officials at the FDA have the same influence as Richard Pazdur, M.D. In 2023, the Oncology Center of Excellence (OCE) under his leadership doled out 83 therapeutic approvals, including 14...
- Dr. Richard Pazdur: 25 Years of Transforming Oncology Drug Development ...In a career that spans nearly half a century in oncology, including 25 years at the U.S. Food and Drug Administration (FDA), Dr. Richard Pazdur has redefined the agency’s role in oncology drug development.As the director of the FDA’s Oncology Center of Excellence (OCE), he has overseen revolutionizing changes in the development of oncology drugs, fostering a transformative impact on ...
- First person profile: Richard Pazdur, MD - Cancer Sco esince arriving at the US Food and Drug Administration (FDA) in 1999, Richard Pazdur, MD, has been on a mission to improve the development of new oncology drugs. More than. 20 years later, he is just as dedicated to achieving that goal. “When I began my career in 1979, there were approximately. 30 to 40 oncology drugs in total.
- Richard Pazdur - WikipediaRichard Pazdur is an American oncologist serving as the founding director of the Oncology Center of Excellence within the Food and Drug Administration. He was appointed to the position in 2005. He was previously the director of the FDA's Office of Hematology Oncology Products from 1999 to 2005. [1]
- The On- and Off-Ramps of Oncology Accelerated ApprovalTo address ongoing concerns about the implementation of the FDA’s Accelerated Approval pathway in oncology, a comprehensive strategy is needed — one that equally emphasizes “on-ramp” and...
More
